University Hospital Heidelberg
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Geriatric-oncological Study on Quality of Life and Independence After Radiotherapy
Completed
- Conditions
- CancerAge <70
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 20
- Registration Number
- NCT05187845
- Locations
- 🇩🇪
University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Attachment, Patient Self-disclosure and Psychotherapy Outcome
Completed
- Conditions
- Treatment OutcomeAttachmentPsychotherapySelf Disclosure
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 1500
- Registration Number
- NCT05151354
Interplay of Self-Criticism and Symptom Severity Over the Course of In-patient Psychotherapeutic Treatment
Completed
- Conditions
- Psychological DistressSelf-CriticismIn-Patient Treatment
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 2778
- Registration Number
- NCT05120453
IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms
Not Applicable
Active, not recruiting
- Conditions
- Graft Vs Host Disease
- Interventions
- Behavioral: Nutritional endorsementBehavioral: Supervised resistance training plus nutritional endorsement
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 112
- Registration Number
- NCT05111834
- Locations
- 🇩🇪
Heidelberg University Hospital, Heidelberg, Germany
The Myeloid Neoplasms Biology and Outcome Project
Recruiting
- Conditions
- Myeloid Neoplasm
- First Posted Date
- 2021-10-12
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 1000
- Registration Number
- NCT05074316
- Locations
- 🇩🇪
UHHeidelberg, Heidelberg, Baden-Württemberg, Germany
Intraoral Scanning Accuracy in the Edentulous Mandible
Completed
- Conditions
- Jaw, EdentulousDental Impression Techniques
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 16
- Registration Number
- NCT05032170
- Locations
- 🇩🇪
Department of Prosthetic Dentistry, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases
Phase 2
Recruiting
- Conditions
- Hepatic Metastasis
- Interventions
- Radiation: MRgSBRT (Magnetic Resonance-guided Stereotactic Body Radiotherapy)Radiation: ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT)
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 90
- Registration Number
- NCT05027711
- Locations
- 🇩🇪
University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions
Not Applicable
Recruiting
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Radiation: ProtonsRadiation: carbon ions
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 42
- Registration Number
- NCT04946357
- Locations
- 🇩🇪
University Hospital Heidelberg, Department of RadioOncology, Heidelberg, Baden-Württemberg, Germany
Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location
Phase 1
Recruiting
- Conditions
- Lung Cancer
- Interventions
- Radiation: Stereotactic body radiotherapy (SBRT)
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 38
- Registration Number
- NCT04925583
- Locations
- 🇩🇪
University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC
Phase 2
Recruiting
- Conditions
- NSCLC, Stage IIIANSCLC Stage IINSCLC Stage IIIB
- Interventions
- First Posted Date
- 2021-04-29
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 20
- Registration Number
- NCT04865250
- Locations
- 🇩🇪
Thoraxklinik Heidelberg gGmbH, Heidelberg, BaWü, Germany